SEC Form 4 · accession 0001179110-17-010216
IDERA PHARMACEUTICALS, INC. · IDRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Youssef El Zein
Director · 10% Owner
Period of report
Jul 3, 2017
Accepted (ET)
Jul 7, 2017 · 1:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000861838
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 3, 2017 | A | 6,151 | $1.75 | A | 530,259 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This stock was issued to the reporting person pursuant to his election under the Issuer's director compensation program in lieu of cash.
Remarks
Please see attached Power of Attorney